ArticleFrontiers in pharmacology2025
Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide. An analytical cross-sectional study was carried out to validate and assess the perception of a group of residents of Mexico City and the metropolitan area regarding the problem of falsified drugs and the risks they entail, along with the purchase of medicines at unauthorized points of sale. In addition, variables associated with buying or not buying at these points of sale were identified. The results suggest that even in a sample of mainly young adults, the potential exposition to collateral effects related to the consumption of falsified or counterfeit medicines is high. Although the participants recognized that these medicines are not safe, they are not familiar with the efforts or information of the corresponding authority to warn them of this problem. In addition, low awareness of the real implications of their nature and their possible impact on heath was identified, suggesting that the falsified and counterfeit medicines' market is a substantial and understudied issue among the Mexican population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.